Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoblastic Lymphadenopathy 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

pembrolizumab 155 Gemcitabine 139 Capecitabine 121 Paclitaxel 118 Fluorouracil 116 Oxaliplatin 110 Bevacizumab 104 Nivolumab 97 Leucovorin 97 Docetaxel 92 Cisplatin 89 Irinotecan 87 Carboplatin 84 Radiosurgery 83 Cyclophosphamide 70 Cetuximab 70 Magnetic Resonance Spectroscopy 68 Trastuzumab 56 Specimen Handling 56 Biopsy 56 Radiotherapy 55 Ipilimumab 52 Everolimus 48 Pemetrexed 46 Drug Therapy 45 Albumin-Bound Paclitaxel 44 130-nm albumin-bound paclitaxel 43 Doxorubicin 41 Fulvestrant 38 aldesleukin 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasm Metastasis × Base Sequence × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡